Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

• Status: Completed
• Trial end date: 2018-10-22
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if intrathecal hydromorphone will relieve pain as well as intrathecal morphine after cesarean delivery, with fewer side effects.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Grace Shih, MD
• Collaborator: Masimo Corporation
• Treatments: Hydromorphone; Morphine

Criteria

Inclusion Criteria:

• Scheduled for elective Cesarean sections under spinal anesthesia or combined spinal anesthesia

• ASA status of I-III

• BMI < 40

• Able to understand and sign informed consent

Exclusion Criteria:

• Severe pre-eclampsia

• Conversion to general anesthetic

• History of chronic opioid use

• Allergy to morphine, or hydromorphone

• Hyperemesis gravidarum

• Emergency case

• Patients who have an infection at the intended site of spinal insertion